In 2000 was created Hummingbird Ventures, which is appeared as VC. The company was established in Europe in Belgium. The leading representative office of defined VC is situated in the Gent.
We also calculated 2 valuable employees in our database.
Among the most popular portfolio startups of the fund, we may highlight Kraken Bitcoin Exchange, Deliveroo, Showpad. Among the most popular fund investment industries, there are Health Care, Financial Services. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. For fund there is no match between the location of its establishment and the land of its numerous investments - United Kingdom. The fund has no exact preference in some founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little.
The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the Hummingbird Ventures, startups are often financed by Y Combinator, Index Ventures, Swisscom Ventures. The meaningful sponsors for the fund in investment in the same round are Y Combinator, Nevzat Aydin, Kaan Karamanci. In the next rounds fund is usually obtained by VentureSouq, Insight Partners, Index Ventures.
The increased amount of exits for fund were in 2017. Opposing the other organizations, this Hummingbird Ventures works on 16 percentage points less the average amount of lead investments. The fund is generally included in 2-6 deals every year. Deals in the range of 10 - 50 millions dollars are the general things for fund. The top activity for fund was in 2019. Speaking about the real fund results, this VC is 1 percentage points less often commits exit comparing to other organizations.
Related Funds
Fund Name | Location |
Backcast Partners | New York, New York, United States |
BuenTrip Ventures | Ecuador, Pichincha, Quito |
E.ON Venture Partners | Düsseldorf, Germany, Nordrhein-Westfalen |
Exor | Croatia, Grad Zagreb, Zagreb |
Fortino Capital | Belgium, Vlaams-Brabant, Zaventem |
Gladium | Gothenburg, Sweden, Vastra Gotaland |
iFund | Japan, Tokyo |
KDG | Beijing, Beijing, China |
LD Capital | China, Shanghai, Shanghai |
Lufthansa Cargo | Frankfurt, Germany, Hessen |
MAGIX | Nevada, Reno, United States |
Net Fund Europe | - |
Nihonshokken | Ehime Prefecture, Imabari, Japan |
Pearson | England, London, United Kingdom |
Rosseau Asset Management | Canada, Ontario, Toronto |
Spinventure | Angleur, Belgium, Liege |
Taihuoniao | Beijing, Beijing, China |
Technology 9 Labs (T9L) | Delhi, India, New Delhi |
Teligence Capital | British Columbia, Canada, Vancouver |
WaterBridge Ventures | Delhi, India, New Delhi |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Basecamp Research | 09 Oct 2024 | London, England, United Kingdom | |||
Lovable | 07 Oct 2024 | Stockholm, Södermanland, Sweden | |||
Salient Motion | 01 Oct 2024 | Irvine, California, United States | |||
Starpath Robotics | $12M | 20 Aug 2024 | San Francisco, California, United States | ||
Waypoint Bio | $14M | 28 Jun 2024 | New York, New York, United States | ||
Etched.ai | $120M | 25 Jun 2024 | San Francisco, California, United States | ||
Leya | $10M | 16 May 2024 | Stockholm, Södermanland, Sweden | ||
Anima | $12M | 19 Mar 2024 | London, England, United Kingdom | ||
Bioptimus | $35M | 20 Feb 2024 | Paris, Ile-de-France, France |
– BillionToOne, Inc. from Menlo Park develops molecular diagnostics company.
– The company closed a $55m Series B funding round.
– The round was led by existing investor Hummingbird Ventures and incoming investor Four Rivers Group with participation from Neotribe Ventures, Norwest Venture Partners, Y Combinator, and Libertus Capital.
– The new investment will be used to expand the company’s clinical lab and commercial team nationwide.
– Enveda Biosciences announced an oversubscribed $51M Series A funding round.
– The financing was led by Lux Capital with participation from Two Sigma Ventures, Hummingbird VC, Catalio Capital, Lifeforce Capital, and Matthew De Silva of Notable Labs along with existing investors True Ventures, Wireframe Ventures, Village Global, and Chris Gibson of Recursion.
– Nature is the greatest source of therapeutics we know, yet 95 percent of the natural world is a chemical mystery. Enveda is systematically exploring this unknown space to unlock its potential for new medicines with the first high-resolution chemical map of the natural world.
– This new investment will further power Enveda’s data-driven approach to screening, validating, and developing high-potential natural compounds into first-in-class clinical candidates.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Basecamp Research | 09 Oct 2024 | London, England, United Kingdom | |||
Lovable | 07 Oct 2024 | Stockholm, Södermanland, Sweden | |||
Salient Motion | 01 Oct 2024 | Irvine, California, United States | |||
Starpath Robotics | $12M | 20 Aug 2024 | San Francisco, California, United States | ||
Waypoint Bio | $14M | 28 Jun 2024 | New York, New York, United States | ||
Etched.ai | $120M | 25 Jun 2024 | San Francisco, California, United States | ||
Leya | $10M | 16 May 2024 | Stockholm, Södermanland, Sweden | ||
Anima | $12M | 19 Mar 2024 | London, England, United Kingdom | ||
Bioptimus | $35M | 20 Feb 2024 | Paris, Ile-de-France, France |